Cargando…
Linezolid resistant coagulase negative staphylococci (LRCoNS) with novel mutations causing blood stream infections (BSI) in India
BACKGROUND: Coagulase-negative Staphylococci (CoNS) have emerged as a major causative agent of blood-stream infections (BSI). Linezolid (LZD) is currently used for treating glycopeptide and methicillin-resistant staphylococci. It is important to understand the resistance mechanism and probable trans...
Autores principales: | Mittal, Gajanand, Bhandari, Vasundhra, Gaind, Rajni, Rani, Vandana, Chopra, Shimpi, Dawar, Reetika, Sardana, Raman, Verma, P. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694603/ https://www.ncbi.nlm.nih.gov/pubmed/31412801 http://dx.doi.org/10.1186/s12879-019-4368-6 |
Ejemplares similares
-
Global Expansion of Linezolid-Resistant Coagulase-Negative Staphylococci
por: Gostev, Vladimir, et al.
Publicado: (2021) -
Mechanisms of Linezolid Resistance among Coagulase-Negative Staphylococci Determined by Whole-Genome Sequencing
por: Tewhey, Ryan, et al.
Publicado: (2014) -
Trends in coagulase-negative staphylococci (CoNS), England, 2010–2021
por: Paranthaman, Karthik, et al.
Publicado: (2023) -
Linezolid-resistant mucoid Staphylococcus haemolyticus from a tertiary-care centre in Delhi
por: Matlani, M., et al.
Publicado: (2016) -
Cfr-Mediated Linezolid-Resistance among Methicillin-Resistant Coagulase-Negative Staphylococci from Infections of Humans
por: Cui, Lanqing, et al.
Publicado: (2013)